Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that allows surgeons to replace a narrowed aortic valve without performing traditional open-heart surgery. According to the American Heart Association, this procedure is primarily indicated for patients with severe symptomatic aortic stenosis who are deemed at high or intermediate risk for standard surgical valve replacement.
How TAVR Works
During a TAVR procedure, a cardiologist or surgeon inserts a catheter—a thin, flexible tube—into a blood vessel, usually in the groin. The team guides the catheter through the artery to the heart, where a new valve is compressed and delivered into the position of the damaged aortic valve. Once the new valve reaches the target site, it is deployed, often expanding to push the old valve leaflets aside and taking over the function of regulating blood flow from the heart to the rest of the body.
Unlike traditional surgical aortic valve replacement (SAVR), which requires a sternotomy (opening the chest) and the use of a heart-lung bypass machine, TAVR is often performed while the heart is still beating. According to the Cleveland Clinic, this approach significantly reduces recovery time for many patients.
Determining Patient Eligibility
Clinical teams evaluate candidates for TAVR using a multidisciplinary approach known as a "Heart Team." This team typically includes interventional cardiologists, cardiothoracic surgeons, and imaging specialists. The decision to recommend TAVR over traditional surgery relies on several factors:
- Surgical Risk Scores: Physicians use standardized scoring systems, such as the STS (Society of Thoracic Surgeons) score, to estimate the risk of mortality and complications associated with open-heart surgery.
- Anatomical Suitability: Imaging tests, such as CT scans and echocardiograms, determine if the patient’s vascular anatomy can safely accommodate the catheter and if the heart structure is a match for the available valve devices.
- Frailty and Comorbidities: The team assesses the patient’s overall physical health, age, and existing medical conditions that might complicate recovery from major surgery.
Recovery and Potential Risks
Most patients who undergo TAVR experience a shorter hospital stay compared to those who undergo traditional surgery, often returning home within one to three days. However, the procedure is not without risks. According to the Mayo Clinic, potential complications include:
- Stroke
- Vascular damage at the insertion site
- Arrhythmias requiring a permanent pacemaker
- Bleeding or infection
- Valve leakage (paravalvular regurgitation)
Comparison of Aortic Valve Treatments
| Feature | Surgical Aortic Valve Replacement (SAVR) | Transcatheter Aortic Valve Replacement (TAVR) |
|---|---|---|
| Invasiveness | High (Open chest) | Low (Minimally invasive) |
| Anesthesia | General anesthesia | Often conscious sedation or general anesthesia |
| Hospital Stay | Typically 5–7 days | Typically 1–3 days |
| Recovery Time | Several months | Several weeks |
Patients should discuss the long-term durability of transcatheter valves with their cardiologist, as data regarding the longevity of these devices compared to mechanical surgical valves continues to evolve through ongoing clinical trials and registry data.
Worth a look